Charles Schwab Investment Management Inc Blueprint Medicines Corp Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 597,232 shares of BPMC stock, worth $52.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
597,232
Previous 546,496
9.28%
Holding current value
$52.2 Million
Previous $58.9 Million
6.25%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$581 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$471 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$347 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$242 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.22B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...